BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 38658783)

  • 1. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
    Liu L; Qin H; Ye M
    Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.
    Ratnavelu ND; Brown AP; Mallett S; Scholten RJ; Patel A; Founta C; Galaal K; Cross P; Naik R
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD010360. PubMed ID: 26930463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.
    Dhar C; Ramachandran P; Xu G; Pickering C; Čaval T; Wong M; Rice R; Zhou B; Srinivasan A; Aiyetan P; Chu CW; Moser K; Herzog TJ; Olawaiye AB; Jacob F; Serie D; Lindpaintner K; Schwarz F
    Br J Cancer; 2024 Jun; 130(10):1716-1724. PubMed ID: 38658783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer.
    Hu Y; Zhu Y; Zhang W; Lang J; Ning L
    Onco Targets Ther; 2019; 12():9715-9723. PubMed ID: 32009804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of Potential Diagnostic Value of Protein Content in Serum Small Extracellular Vesicles for Early-Stage Epithelial Ovarian Carcinoma.
    Li P; Bai Y; Shan B; Zhang W; Liu Z; Zhu Y; Xu X; Chen Q; Sheng X; Deng X; Guo Z; Zhang D; Wang H; Zhang Y; Hu Y
    Front Oncol; 2021; 11():707658. PubMed ID: 34604046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGAL/MMP-9 as a Biomarker for Epithelial Ovarian Cancer: A Case-Control Diagnostic Accuracy Study.
    Gupta RK; Dholariya S; Radadiya M; Agarwal P
    Saudi J Med Med Sci; 2022; 10(1):25-30. PubMed ID: 35283706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.
    Kim K; Ruhaak LR; Nguyen UT; Taylor SL; Dimapasoc L; Williams C; Stroble C; Ozcan S; Miyamoto S; Lebrilla CB; Leiserowitz GS
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):611-21. PubMed ID: 24557531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.
    Ning L; Lang J; Wu L
    BMC Cancer; 2022 Jan; 22(1):6. PubMed ID: 34980005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy: from concept to clinical application.
    Alix-Panabières C; Marchetti D; Lang JE
    Sci Rep; 2023 Dec; 13(1):21685. PubMed ID: 38066040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics.
    Čaval T; Alisson-Silva F; Schwarz F
    Theranostics; 2023; 13(8):2605-2615. PubMed ID: 37215580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsies: the future of cancer early detection.
    Connal S; Cameron JM; Sala A; Brennan PM; Palmer DS; Palmer JD; Perlow H; Baker MJ
    J Transl Med; 2023 Feb; 21(1):118. PubMed ID: 36774504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer statistics, 2023.
    Siegel RL; Miller KD; Wagle NS; Jemal A
    CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging promise of liquid biopsies in solid tumors.
    Pappas L; Adalsteinsson VA; Parikh AR
    Nat Cancer; 2022 Dec; 3(12):1420-1422. PubMed ID: 36539493
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of the Adnexal Mass: Considerations for the Family Medicine Physician.
    Bullock B; Larkin L; Turker L; Stampler K
    Front Med (Lausanne); 2022; 9():913549. PubMed ID: 35865172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases.
    Jin Y; Wang W; Wang Q; Zhang Y; Zahid KR; Raza U; Gong Y
    Cancer Cell Int; 2022 Apr; 22(1):156. PubMed ID: 35439996
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.